REPLIGEN CORP Contract with Customer, Performance Obligation Satisfied in Previous Period
REPLIGEN CORP (RGEN) reported Contract with Customer, Performance Obligation Satisfied in Previous Period of $0 for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-07-27.
Discontinued › Notes
us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod · last filed 2021-07-27
- REPLIGEN CORP contract with customer, performance obligation satisfied in previous period for the quarter ending 2021-06-30 was $0.00.
- REPLIGEN CORP contract with customer, performance obligation satisfied in previous period for the quarter ending 2021-03-31 was $0.00.
- REPLIGEN CORP contract with customer, performance obligation satisfied in previous period for the quarter ending 2018-12-31 was $0.00.
- REPLIGEN CORP contract with customer, performance obligation satisfied in previous period for the quarter ending 2018-09-30 was $0.00.
- REPLIGEN CORP contract with customer, performance obligation satisfied in previous period for fiscal 2018 was $0.00.
| Period end | Contract with Customer, Performance Obligation Satisfied in Previous Period 3 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 6 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 9 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 12 month |
|---|---|---|---|---|
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $0.00 10-Q · filed 2021-07-27 | ||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-04 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $0.00 derived: sum of 3 quarters · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | ||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |